THREE new non-executive directors have joined the Isle of Wight NHS Trust board.
Jessamy Baird, from pharmaceutical company Eli Lilley and Co, David King, previously of Intel Corporation, and Jane Tabor, previously of IBM, have been appointed to help the organisation achieve foundation trust status.
Trust chairman Danny Fisher said: "We identified the need for more business, commercial and marketing skills on the board. Our three new non-executive directors bring a great deal of experience from the pharmaceutical and information technology sectors which we were unable to secure from Island candidates. Two also have previous board level experience of the NHS.
"There will be significant change in the NHS, both nationally and locally, over the next ten years and our new directors are ideally placed to support us as we move towards becoming a foundation trust."
Mr King, who is a UKSA trustee, said: "I have a strong commitment to the growth of community based care and I want to help the trust meet the significant challenges of providing care to an ageing population with limited resources."
All three will take up their roles from January 1, and will be paid £6,157 per year.